China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Innovent Biologics (IVBIY) secures second Chinese approval for lung cancer therapy Dovbleron developed with U.S. biotech ...

Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Researchers have discovered why the lungs are often targeted by metastasizing cancer cells, pinpointing the amino acid ...

The family of a retired Westchester school employee is reaching out to the community for help as they raise funds for a ...

From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...

Lung cancer remains one of the most common and lethal forms of cancer worldwide, particularly in men. Despite advances in treatment, late detection often limits ...

Sacituzumab govitecan, currently indicated in triple-negative breast cancer (TNBC), is undergoing evaluation in NSCLC. In ...